KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Merck (MRK) Other financing activities (2016 - 2025)

Merck (MRK) has disclosed Other financing activities for 17 consecutive years, with $121.0 million as the latest value for Q4 2025.

  • Quarterly Other financing activities rose 388.1% to $121.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$131.0 million through Dec 2025, up 64.78% year-over-year, with the annual reading at -$131.0 million for FY2025, 64.78% up from the prior year.
  • Other financing activities for Q4 2025 was $121.0 million at Merck, up from $2.0 million in the prior quarter.
  • The five-year high for Other financing activities was $121.0 million in Q4 2025, with the low at -$251.0 million in Q4 2021.
  • Average Other financing activities over 5 years is -$78.8 million, with a median of -$73.0 million recorded in 2022.
  • The sharpest move saw Other financing activities tumbled 1300.0% in 2024, then skyrocketed 388.1% in 2025.
  • Over 5 years, Other financing activities stood at -$251.0 million in 2021, then surged by 72.91% to -$68.0 million in 2022, then skyrocketed by 95.59% to -$3.0 million in 2023, then crashed by 1300.0% to -$42.0 million in 2024, then soared by 388.1% to $121.0 million in 2025.
  • According to Business Quant data, Other financing activities over the past three periods came in at $121.0 million, $2.0 million, and -$194.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.